Cytokinetics, Incorporated - Penyata Pendapatan (TTM)

Cytokinetics, Incorporated
US ˙ NasdaqGS ˙ US23282W6057

Penyata Pendapatan (TTM)

Cytokinetics, Incorporated Penyata Pendapatan menunjukkan perubahan dalam pendapatan dan perbelanjaan sepanjang tempoh masa tertentu. Data Penyata Pendapatan termasuk Jualan dan Hasil, Untung Kasar, Penyelidikan dan Pembangunan (R&D), Jualan, Perbelanjaan Am dan Pentadbiran (SG&A), Pendapatan Operasi, Perbelanjaan Cukai Pendapatan, Perbelanjaan Faedah, Pendapatan Bukan Operasi, Perolehan sesaham (EPS), dan Saham Diterbitkan.

Semua nombor adalah kali 1,000,000 kecuali setiap unit saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Hasil 54 56 59 58 22 70 65 151 148 95 98 10 8 8 4 3 3 18 19 86
Perubahan (%) 2.78 4.88 -1.28 -62.72 226.81 -7.67 132.44 -1.93 -36.19 3.66 -89.85 -21.47 -3.65 -50.17 -16.47 2.71 473.90 4.03 346.13
% daripada Hasil 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Kos jualan 86 97 107 121 146 160 174 195 209 241 274 300 320 330 332 329 331 339 358 391
Perubahan (%) 12.65 10.13 13.72 19.96 9.80 8.99 11.87 7.33 15.06 13.91 9.50 6.59 3.11 0.65 -1.08 0.63 2.62 5.38 9.21
% daripada Hasil 158.44 173.66 182.36 210.08 675.92 227.09 268.06 129.01 141.19 254.59 279.75 3,018.16 4,096.80 4,384.10 8,855.86 10,487.40 10,275.09 1,837.22 1,861.17 455.62
Keuntungan Operasi Kasar -32 -41 -48 -64 -124 -90 -109 -44 -61 -146 -176 -290 -312 -323 -329 -326 -328 -321 -338 -305
Perubahan (%) 29.54 17.27 31.94 95.06 -27.88 22.09 -59.88 39.28 139.47 20.53 64.78 7.55 3.28 1.84 -0.91 0.61 -2.02 5.46 -9.92
% daripada Hasil -58.44 -73.66 -82.36 -110.08 -575.92 -127.09 -168.06 -29.01 -41.19 -154.59 -179.75 -2,918.16 -3,996.80 -4,284.10 -8,755.86 -10,387.40 -10,175.09 -1,737.22 -1,761.17 -355.62
SG&A 49 53 56 63 77 97 114 136 158 178 195 192 183 174 169 181 197 215 227 242
Perubahan (%) 6.72 5.96 12.57 22.06 25.87 18.05 18.83 16.22 12.78 9.32 -1.54 -4.23 -5.37 -2.40 6.55 9.16 9.25 5.51 6.56
% daripada Hasil 91.12 94.61 95.59 109.00 356.87 137.45 175.73 89.84 106.46 188.16 198.44 1,925.02 2,347.63 2,305.60 4,516.18 5,760.98 6,122.71 1,165.50 1,182.14 282.35
R&D
Perubahan (%)
% daripada Hasil
OpEx 136 150 163 184 223 257 289 331 367 419 469 492 504 504 502 509 528 555 585 633
Perubahan (%) 10.48 8.66 13.33 20.68 15.35 12.40 14.62 10.98 14.08 11.96 4.92 2.38 0.02 -0.40 1.50 3.66 5.09 5.43 8.18
% daripada Hasil 249.57 268.27 277.95 319.08 1,032.79 364.54 443.79 218.84 247.66 442.75 478.18 4,943.18 6,444.43 6,689.71 13,372.04 16,248.37 16,397.79 3,002.72 3,043.30 737.96
Pendapatan operasi -81 -94 -104 -127 -201 -186 -224 -180 -219 -324 -371 -482 -496 -496 -498 -506 -525 -536 -566 -547
Perubahan (%) 15.63 10.91 21.54 58.74 -7.31 19.99 -19.65 21.84 48.12 14.38 29.98 2.87 0.08 0.36 1.63 3.66 2.22 5.48 -3.30
% daripada Hasil -149.57 -168.27 -177.95 -219.08 -932.79 -264.54 -343.79 -118.84 -147.66 -342.75 -378.18 -4,843.18 -6,344.43 -6,589.71 -13,272.04 -16,148.37 -16,297.79 -2,902.72 -2,943.30 -637.96
Perbelanjaan Faedah -37 -39 -36 -33 -31 -29 -32 -35 -43 -51 -55 -59 -57 -58 -62 -73 -81 -87 -92 -92
Perubahan (%) 3.77 -7.71 -8.01 -7.07 -3.87 8.62 9.00 24.91 17.94 7.68 6.46 -3.02 1.40 7.07 17.70 11.42 6.83 6.50 -0.04
% daripada Hasil -68.62 -69.28 -60.96 -56.80 -141.59 -41.65 -48.99 -22.97 -29.26 -54.08 -56.18 -589.27 -727.74 -765.84 -1,645.74 -2,319.08 -2,515.75 -468.29 -479.43 -107.42
Pendapatan bersih -114 -127 -135 -156 -229 -215 -258 -216 -282 -389 -431 -540 -527 -526 -531 -545 -576 -590 -615 -606
Perubahan (%) 11.66 6.05 15.39 46.81 -5.84 19.66 -16.20 30.67 37.86 10.76 25.26 -2.39 -0.09 0.83 2.77 5.71 2.28 4.37 -1.45
% daripada Hasil -209.88 -228.00 -230.55 -269.48 -1,061.13 -305.72 -396.22 -142.85 -190.34 -411.21 -439.35 -5,422.19 -6,739.96 -6,988.63 -14,141.74 -17,398.82 -17,906.24 -3,191.11 -3,201.47 -707.17

Source: Capital IQ

Other Listings
IT:1CYTK €44.00
DE:KK3A €42.20
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista